Matching
Match the term with its description.
Premises:
dexamethasone
lenalidomide
phosphoantigen
elotuzumab
bortezomib
ADAM33 metalloproteinase
Responses:
proteasome inhibitor
opsonizes tumor cells
immunosuppressive steroid
blocks new blood vessel formation
promotes shedding of FcγRIII from NK-cell surfaces
activates γ:δ T cells
Correct Answer:
Premises:
Responses:
dexamethasone
lenalidomide
phosphoantigen
elotuzumab
bortezomib
ADAM33 metalloproteinase
Premises:
dexamethasone
lenalidomide
phosphoantigen
elotuzumab
bortezomib
ADAM33 metalloproteinase
Responses:
Related Questions
Q17: A.What is Li-Fraumeni syndrome?<br>B.What is the underlying
Q18: Provide an example of a monoclonal antibody
Q19: A protein expressed in response to damage
Q20: Li-Fraumeni syndrome is linked to a greater
Q21: A mechanism by which cancer cells can
Q23: A.What are the two main classes of
Q24: Which cytokines are associated with tumor-induced suppression
Q25: Which of the following are true for
Q26: When the immune system is involved in
Q27: Explain how the immune mechanisms for the